SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001062993-18-001883
Filing Date
2018-05-02
Accepted
2018-05-02 12:40:36
Documents
1
Effectiveness Date
2018-05-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10835
  Complete submission text file 0001062993-18-001883.txt   11874
Mailing Address 2100 BLOOR ST. WEST, SUITE 6339 TORONTO A6 M6S 5A5
Business Address 2100 BLOOR ST. WEST, SUITE 6339 TORONTO A6 M6S 5A5 647-341-8033
Xanthic Biopharma Inc. (Filer) CIK: 0001739376 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-311493 | Film No.: 18798578